ROBERT L. VAN NOSTRAND - 14 Jun 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
14 Jun 2024
Transactions value $
$0
Form type
4
Filing time
18 Jun 2024, 18:00:10 UTC
Previous filing
02 Apr 2024
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Award $0 +2.95K $0.00 2.95K 14 Jun 2024 Common Stock 2.95K Direct F1, F2
transaction ITCI Stock Option (right to buy) Award $0 +4.32K $0.00 4.32K 14 Jun 2024 Common Stock 4.32K $67.77 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025).